Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

Dendritic cell vaccination in acute myeloid leukemia

(2014) Sébastien Anguille et al.   CYTOTHERAPY

Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles

(2014) C. Chauvin et al.   JOURNAL OF IMMUNOLOGY

IFN-  Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo

(2014) C. Papewalis et al.   JOURNAL OF IMMUNOLOGY

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities

(2012) J. Tel et al.   BLOOD

IL-15 activated human peripheral blood dendritic cell kill allogeneic and xenogeneic endothelial cells via apoptosis

(2012) Partha Pratim Manna et al.   CYTOKINE

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells

(2012) Barbara Drobits et al.   JOURNAL OF CLINICAL INVESTIGATION

TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN- -Mediated Antitumor Reactivity

(2012) M. L. Kalb et al.   JOURNAL OF IMMUNOLOGY

Plasmacytoid Dendritic Cells (pDCs) From HIV Controllers Produce Interferon-α and Differentiate Into Functional Killer pDCs Under HIV Activation

(2012) Lucie Barblu et al.   JOURNAL OF INFECTIOUS DISEASES

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia

(2012) S Anguille et al.   LEUKEMIA

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

(2012) Elena Provasi et al.   NATURE MEDICINE

Dendritic cell vaccine therapy for acute myeloid leukemia: Questions and answers

(2011) Sébastien Anguille et al.   Human vaccines & immunotherapeutics

T cell killing by tolerogenic dendritic cells protects mice from allergy

(2011) Ulrike Luckey et al.   JOURNAL OF CLINICAL INVESTIGATION

Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN- -Dependent Mechanism

(2011) C. J. LaCasse et al.   JOURNAL OF IMMUNOLOGY

A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer

(2011) Gary K. Koski et al.   JOURNAL OF IMMUNOTHERAPY

Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15

(2011) Kristina M. Harris   JOURNAL OF LEUKOCYTE BIOLOGY

Interferon-α in acute myeloid leukemia: an old drug revisited

(2011) S Anguille et al.   LEUKEMIA

Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells

(2011) Jerome Thiery et al.   NATURE IMMUNOLOGY

Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC

(2011) Eva Lion et al.   PLoS One

Connecting the dots: monocyte/DC and NK subsets in human peripheral blood

(2010) V. Bigley et al.   BLOOD

IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion

(2010) Margareta P. Correia et al.   IMMUNOBIOLOGY

Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4

(2009) J. M. Milush et al.   BLOOD

Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

(2009) Elizabeth M Urban et al.   BMC IMMUNOLOGY

Killer dendritic cells and their potential for cancer immunotherapy

(2009) Nicolas Larmonier et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dendritic Cell-Based Cancer Gene Therapy

(2009) Evelien L.J.M. Smits et al.   HUMAN GENE THERAPY

CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions

(2009) T. Matsui et al.   JOURNAL OF IMMUNOLOGY

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

(2009) Sébastien Anguille et al.   Journal of Translational Medicine

Isopentenyl Pyrophosphate-Activated CD56+    T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma

(2008) A. A.Z. Alexander et al.   CLINICAL CANCER RESEARCH